Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study
- PMID: 27556398
- PMCID: PMC4996502
- DOI: 10.1371/journal.pone.0160850
Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study
Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Executive dysfunction is common in patients with ALS, with up to 50% of patients performing within an impaired range. There is evidence that social cognitive deficits associated with ALS are a function of deficits in executive function. The 'Reading the Mind in the Eyes' Test is a recognized test of social cognitive function, although the reliability of this instrument remains to be established.
Methodology: Patients with ALS (n = 106), and age and IQ matched controls (n = 50) were recruited and asked to perform the Reading the Mind in the Eyes Test as part of an on-going population-based study of cognitive function. ALS patients were sub-stratified based on the presence, and/or extent of executive dysfunction.
Results: Cronbach's Alpha of .73 was observed, indicating good reliability on this measure. Split-half reliability analysis further confirms these findings (p = 0.826). The Reading the Mind in the Eyes test had excellent psychometric properties when discriminating between ALS patients who are cognitively intact, and those who have executive impairment, with an overall medium difficulty. There was a large magnitude significant difference between patients and controls (p< 0.001; η2 = .19). Post-hoc analysis revealed that controls performed significantly higher than patients with executive impairment (p< 0.001), and patients with single executive deficits (p = 0.002).
Conclusion: Executive dysfunction impacts on social cognitive performance. This study contributes not only to the psychometric knowledge of this measure, but also to the usability, efficacy, and reliability of social cognitive assessment in ALS. Using population-specific normative data, we confirm the Reading the Mind in the Eyes Test is a reliable measure of social cognitive processes in ALS.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis.Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct-Nov;17(7-8):467-472. doi: 10.1080/21678421.2016.1177088. Epub 2016 May 6. Amyotroph Lateral Scler Frontotemporal Degener. 2016. PMID: 27152765
-
Neural substrate of cognitive theory of mind impairment in amyotrophic lateral sclerosis.Cortex. 2015 Apr;65:19-30. doi: 10.1016/j.cortex.2014.12.010. Epub 2014 Dec 29. Cortex. 2015. PMID: 25618325
-
The reading the mind in the eyes test short form (A & B): validation and outcomes in an amyotrophic lateral sclerosis cohort.Amyotroph Lateral Scler Frontotemporal Degener. 2020 Aug;21(5-6):380-388. doi: 10.1080/21678421.2020.1772824. Epub 2020 Jun 5. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 32501122
-
Cognitive impairment in amyotrophic lateral sclerosis.Lancet Neurol. 2007 Nov;6(11):994-1003. doi: 10.1016/S1474-4422(07)70265-X. Lancet Neurol. 2007. PMID: 17945153 Review.
-
Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment.Lancet Neurol. 2013 Apr;12(4):368-80. doi: 10.1016/S1474-4422(13)70026-7. Epub 2013 Mar 18. Lancet Neurol. 2013. PMID: 23518330 Review.
Cited by
-
NR3C1 and NR3C2 Genes Increase the Risk of Suicide Attempt in Psychiatric Disorder Patients with History of Childhood Trauma.Neuropsychiatr Dis Treat. 2023 Nov 24;19:2561-2571. doi: 10.2147/NDT.S431176. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 38035135 Free PMC article.
-
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.BMJ. 2023 Oct 27;383:e075037. doi: 10.1136/bmj-2023-075037. BMJ. 2023. PMID: 37890889 Free PMC article. Review.
-
Neuropsychological impairment in amyotrophic lateral sclerosis-frontotemporal spectrum disorder.Nat Rev Neurol. 2023 Nov;19(11):655-667. doi: 10.1038/s41582-023-00878-z. Epub 2023 Oct 12. Nat Rev Neurol. 2023. PMID: 37828358 Review.
-
A 20-Year Systematic Review of the 'Reading the Mind in the Eyes' Test across Neurodegenerative Conditions.Brain Sci. 2023 Aug 31;13(9):1268. doi: 10.3390/brainsci13091268. Brain Sci. 2023. PMID: 37759869 Free PMC article. Review.
-
Language deficits in primary lateral sclerosis: cortical atrophy, white matter degeneration and functional disconnection between cerebral regions.J Neurol. 2024 Jan;271(1):431-445. doi: 10.1007/s00415-023-11994-7. Epub 2023 Sep 27. J Neurol. 2024. PMID: 37759084
References
-
- Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive Dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2012;76:1263–1289. - PubMed
-
- Burke T, Elamin M., Galvin M., Hardiman O., & Pender N. (2015). Caregiver burden in amyotrophic lateral sclerosis: a cross sectional investigation of predictors. J Neurol. - PubMed
-
- Giradi A, MacPherson SE, Abrahams S. Deficits in Emotional and Social Cognition in Amyotrophic Lateral Sclerosis. Neuropsychology 2011;25(1):53–65. doi: 10.1037/a0020357 - DOI - PubMed
-
- Abu-Akel A, Shamay-Tsoory S. Neuroanatomical and neurochemical bases of theory of mind. Neuropsychologia 2011;49:2971–84 doi: 10.1016/j.neuropsychologia.2011.07.012 - DOI - PubMed
-
- Adolphs R. The social brain: neural basis of social knowledge. Annu Rev Psychol 2009;60:693–716. doi: 10.1146/annurev.psych.60.110707.163514 - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
